Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
32,307,754
-
Share change
-
-4,799,663
-
Total reported value
-
$171,232,126
-
Put/Call ratio
-
106%
-
Price per share
-
$5.30
-
Number of holders
-
100
-
Value change
-
-$34,224,210
-
Number of buys
-
57
-
Number of sells
-
44
Institutional Holders of KALA BIO INC COM NEW - Stock (KALA) as of Q2 2021
As of 30 Jun 2021,
KALA BIO INC COM NEW - Stock (KALA) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,307,754 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, CAXTON CORP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Samsara BioCapital, LLC, NORTHERN TRUST CORP, and DIMENSIONAL FUND ADVISORS LP.
This page lists
100
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.